NCT00092118View on ClinicalTrials.gov

The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,992

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

Montelukast

one 10 mg tablet, taken once daily at bed time for 6 weeks

DRUG

Comparator: Placebo

one placebo tablet, taken once daily at bed time for 6 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00092118 - The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265) | Biotech Hunter | Biotech Hunter